Draft Guidance for Industry on Environmental Assessment of Human Drug and Biologics Applications; Availability

Resumen

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``Environmental Assessment of Human Drug and Biologics Applications.'' This draft guidance is intended to provide information on when an environmental assessment (EA) should be submitted in support of a human drug or biologics application and recommendations on how to prepare EA's.